» Articles » PMID: 35686682

Prenatal Alcohol Exposure Can Be Determined from Baby Teeth: Proof of Concept

Overview
Date 2022 Jun 10
PMID 35686682
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prenatal alcohol exposure (PAE), leading to fetal alcohol spectrum disorders (FASD), is a serious public health issue in the United States and globally. Diagnosis of FASD is crucial in obtaining appropriate care, but it is not always possible when PAE cannot be documented.

Methods: Deciduous teeth from a child with known PAE and a child with known absence of PAE were analyzed using liquid chromatography-isotope dilution tandem mass spectrometry (LC-IDMS/MS) in a multiple-reaction monitoring mode for direct markers and LC-high resolution MS in positive and negative mode with hydrophilic interaction liquid chromatography and reverse-phase chromatography, respectively, for indirect markers.

Results: Direct markers of PAE (ethyl glucuronide and ethyl sulfate) were detected in prenatal and postnatal dentine from a case tooth but not from a control tooth. Indirect biomarker analysis indicated a dysregulation of amino acids and an increase in cholesterol sulfate in the case compared to the control tooth.

Conclusions: This proof-of-concept study demonstrates for the first time that direct biomarkers of PAE are detectable and measurable in deciduous teeth which begin forming in utero and are typically naturally shed between 5 and 12 years of age. Further examination of these novel biomarkers may allow diagnosis of FASD where documentation of PAE is otherwise unavailable. Furthermore, because teeth grow incrementally, defined growth zones can be sampled allowing for identification of gestational timing of PAE to help better understand mechanisms underlying alcohol's disruption of perinatal development.

Citing Articles

A Case of Hypophosphatasia Started Enzyme Replacement Therapy Since Babyhood Stage.

Akitomo T, Niizato N, Kaneki A, Ogawa M, Nishimura T, Kametani M Children (Basel). 2025; 12(1).

PMID: 39857892 PMC: 11764115. DOI: 10.3390/children12010061.


Fetal alcohol spectrum disorders prevention and clinical guidelines research - workshop report.

Perez Koehlmoos T, Lee E, Rivera I, Wisdahl J, Erdman K, Donaldson T BMC Proc. 2024; 18(Suppl 12):15.

PMID: 39107800 PMC: 11304608. DOI: 10.1186/s12919-024-00298-x.

References
1.
Cattaneo C, Gigli F, Lodi F, Grandi M . The detection of morphine and codeine in human teeth: an aid in the identification and study of human skeletal remains. J Forensic Odontostomatol. 2003; 21(1):1-5. View

2.
Mattson S, Riley E, Gramling L, Delis D, Jones K . Neuropsychological comparison of alcohol-exposed children with or without physical features of fetal alcohol syndrome. Neuropsychology. 1998; 12(1):146-53. DOI: 10.1037//0894-4105.12.1.146. View

3.
Mattson S, Roesch S, Fagerlund A, Autti-Ramo I, Jones K, May P . Toward a neurobehavioral profile of fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2010; 34(9):1640-50. PMC: 2946199. DOI: 10.1111/j.1530-0277.2010.01250.x. View

4.
Vargesson N . Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today. 2015; 105(2):140-56. PMC: 4737249. DOI: 10.1002/bdrc.21096. View

5.
Morishita H, Arora M . Tooth-Matrix Biomarkers to Reconstruct Critical Periods of Brain Plasticity. Trends Neurosci. 2017; 40(1):1-3. PMC: 5215836. DOI: 10.1016/j.tins.2016.11.003. View